Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010. - Wikidata - awgldk - TriplyDB

Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

http://www.wikidata.org/entity/Q35114991

about

PCSK9 inhibition: the way forward in the treatment of dyslipidemia PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era The panorama of familial hypercholesterolemia in Latin America: a systematic review.Efficacy and Safety of Lomitapide in Hypercholesterolemia.An evaluation of alirocumab for the treatment of hypercholesterolemia.Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea.Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration.Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein.European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.Registries, codifications and cardiovascular outcomes in familial hypercholesterolaemia

P2860

Q26784482-10DEDEDE-126F-4A6D-AE8B-07C1188E659C Q28073656-E5FEFC32-C173-4704-B08D-1DA67803B9AB Q30244116-1F9A86C0-8312-48D1-AE92-FBCB1A6BF6C0 Q36296212-ECE58ADA-D794-4E8B-96C1-CCE7BCD7C925 Q38632198-966D6271-82BB-4A5C-B317-EF26CCAC6310 Q38724969-D379A887-AE28-4711-9AFF-91E593F00B0B Q38791223-7F3EAC15-BAA4-43E8-8B00-BE88C0E02AF8 Q38793246-05EF16FC-373C-4733-B3B4-137A113C63E7 Q39236327-411E49BD-14DE-45FB-9F00-013B17AC94B7 Q39455589-BDE3CF5C-D67F-4608-90D3-C8DB2BDE8789 Q42629536-E6A9C946-DF5F-41B9-A7F8-94DABE15CAD4 Q45324898-0EF006DB-05D6-4ECF-8B8D-3EB3EB53000C Q52845873-D673B7D4-C209-461A-9448-C457760F4F80 Q57293348-CAD58137-A143-4625-ABA4-943E4189AAAF

P2860

Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

http://www.wikidata.org/entity/Q35114991

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mortality among patients with ...... ed study in Norway, 1992-2010.

@ast

Mortality among patients with ...... ed study in Norway, 1992-2010.

@en

type

label

Mortality among patients with ...... ed study in Norway, 1992-2010.

@ast

Mortality among patients with ...... ed study in Norway, 1992-2010.

@en

prefLabel

Mortality among patients with ...... ed study in Norway, 1992-2010.

@ast

Mortality among patients with ...... ed study in Norway, 1992-2010.

@en

P1433

Q35114991-0E0A415A-652A-4628-8664-A64A306A8306

P1476

Q35114991-4DD5312D-B22E-4D3B-860B-D4F75E9F063F

P2093

Q35114991-21E2898E-7B25-4DDE-8096-F50BCEBE32FE

Q35114991-2AF5F277-2829-48FB-A689-2BD610B170BC

Q35114991-4957ACAE-EE5E-4F39-A0CC-D645C7C2015E

Q35114991-66A8B7B1-4CFE-4B43-B28E-5F2F90CBFABB

Q35114991-D3F8B11C-5662-413A-8A80-6C05F2487727

Q35114991-F9884D5B-C445-45FA-BACC-52B651623809

P2860

Q35114991-01A39D7B-11C5-4B92-BBA0-B70DC988ADDA

Q35114991-06931067-81A2-4ECD-A775-BED1A894E906

Q35114991-0DEDCBF0-8573-4A8E-906C-F6D30F3F36ED

Q35114991-13D45D93-601E-490F-9E10-BFB97648CD6B

Q35114991-14D0CC05-7D1B-40C0-8E55-9D768513239C

Q35114991-1740EC59-E7B1-4379-9953-372264F314C1

Q35114991-1CA4CC84-B9AE-4EED-8271-67AE38351605

Q35114991-258A9212-CABD-41AF-8250-76EE87A9EF6B

Q35114991-3360EED9-A3FF-4441-B26E-DB4E7F1BA219

Q35114991-35793BB7-CD2B-4287-A232-35BD54DE855F

P304

Q35114991-08B5C1DD-BEB3-4718-AE2D-A24946C9886C

P31

Q35114991-A5F089F8-677A-4B65-A26D-F4D4801F7077

P356

Q35114991-2F456322-4F7D-40C6-A5FE-8921209A6F18

P433

Q35114991-FB974EB9-73E8-420E-BFC2-E6080F17CC57

P478

Q35114991-BBEB01CC-28CC-4EC6-8E5C-6C703397E1AB

P50

Q35114991-BCDFBBD6-2362-4887-9657-DD61F6740D0D

Q35114991-D7DC3DA8-3961-4D8E-BA41-DD1D362F944C

P577

Q35114991-EE7342DC-4243-4E87-ABFC-2FCB675F717B

P698

Q35114991-E81B4E3D-6F0B-4C37-9B1D-6B4327F78BC8

P921

Q35114991-92AE694E-69C2-4D16-BEED-6132BE350175

P932

Q35114991-E8E2303E-E158-4B6C-8444-0D3F6F02EB8D

P356

JAHA.114.001236

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Mortality among patients with ...... ed study in Norway, 1992-2010.

@en

P2093

Jens-Kristian Borgan

http://www.w3.org/2001/XMLSchema#string

Leiv Ose

http://www.w3.org/2001/XMLSchema#string

Liv Mundal

http://www.w3.org/2001/XMLSchema#string

Mirza Sarancic

http://www.w3.org/2001/XMLSchema#string

Per Ole Iversen

http://www.w3.org/2001/XMLSchema#string

Trond P Leren

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

The LDL receptor

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated

[Cause of death registry--an important data source for medical research].

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

Statin use and cancer risk: a comprehensive review

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

P304

e001236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.114.001236

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Marit B. Veierød

Kjetil Retterstøl

P577

2014-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25468658

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

4338710

http://www.w3.org/2001/XMLSchema#string